These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 27099961)

  • 41. Anesthetic management of a patient with an allergy to propylene glycol and parabens.
    Farber MK; Angelo TE; Castells M; Tsen LC
    Anesth Analg; 2010 Mar; 110(3):839-42. PubMed ID: 20185660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved properties of fine active pharmaceutical ingredient powder blends and tablets at high drug loading via dry particle coating.
    Kunnath K; Huang Z; Chen L; Zheng K; Davé R
    Int J Pharm; 2018 May; 543(1-2):288-299. PubMed ID: 29625168
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biowaiver monographs for immediate-release solid oral dosage forms: stavudine.
    Silva AL; Cristofoletti R; Storpirtis S; Sousa VD; Junginger HE; Shah VP; Stavchansky S; Dressman JB; Barends DM
    J Pharm Sci; 2012 Jan; 101(1):10-6. PubMed ID: 21922462
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reflection on the Pharmaceutical Formulation Challenges Associated with a Paediatric Investigation Plan for an Off-Patent Drug.
    Walsh J
    AAPS PharmSciTech; 2017 Feb; 18(2):250-256. PubMed ID: 27097815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction between Different Pharmaceutical Excipients in Liquid Dosage Forms-Assessment of Cytotoxicity and Antimicrobial Activity.
    Nemes D; Kovács R; Nagy F; Mező M; Poczok N; Ujhelyi Z; Pető Á; Fehér P; Fenyvesi F; Váradi J; Vecsernyés M; Bácskay I
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30041418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitigating unwanted amorphisation: A screening method for the selection of suitable excipients.
    Amharar Y; Curtin V; Gallagher KH; O'Siochru E; O'Connell P; Healy AM
    Eur J Pharm Sci; 2016 Jan; 81():181-8. PubMed ID: 26493586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Off-label use and harmful potential of drugs in a NICU in Brazil: A descriptive study.
    de Souza AS; Dos Santos DB; Rey LC; Medeiros MG; Vieira MG; Coelho HLL
    BMC Pediatr; 2016 Jan; 16():13. PubMed ID: 26795213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is rat a good model for assessment of particulate-based taste-masked formulations?
    Ali J; Chiang M; Lee JB; Voronin GO; Bennett J; Cram A; Kagan L; Garnett MC; Roberts CJ; Gershkovich P
    Eur J Pharm Biopharm; 2020 Jan; 146():1-9. PubMed ID: 31726218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial.
    Klingmann V; Pohly CE; Meissner T; Mayatepek E; Möltner A; Flunkert K; Breitkreutz J; Bosse HM
    Eur J Pharm Biopharm; 2020 Jun; 151():239-245. PubMed ID: 32348882
    [TBL] [Abstract][Full Text] [Related]  

  • 51. On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
    Azad MA; Osorio JG; Wang A; Klee DM; Eccles ME; Grela E; Sloan R; Hammersmith G; Rapp K; Brancazio D; Myerson AS
    Pharm Res; 2019 Oct; 36(12):167. PubMed ID: 31650274
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Applications of various analytical techniques in quality control of pharmaceutical excipients.
    Kumar M; Bhatia R; Rawal RK
    J Pharm Biomed Anal; 2018 Aug; 157():122-136. PubMed ID: 29787965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Robustness testing of a tablet formulation using multivariate design.
    Gabrielsson J; Sjöström M; Lindberg NO; Pihl AC; Lundstedt T
    Drug Dev Ind Pharm; 2006 Mar; 32(3):297-307. PubMed ID: 16556534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Direct compression high functionality excipient using coprocessing technique: a brief review.
    Mirani AG; Patankar SP; Borole VS; Pawar AS; Kadam VJ
    Curr Drug Deliv; 2011 Jul; 8(4):426-35. PubMed ID: 21235470
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selective detection of active pharmaceutical ingredients in tablet formulations using solid-state NMR spectroscopy.
    Hong YL; Manjunatha Reddy GN; Nishiyama Y
    Solid State Nucl Magn Reson; 2020 Apr; 106():101651. PubMed ID: 32058901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence.
    García-Arieta A
    Eur J Pharm Sci; 2014 Dec; 65():89-97. PubMed ID: 25236823
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
    Bakri B; Weimer M; Hauck G; Reich G
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Excipient exposure in very low birth weight preterm neonates.
    Akinmboni TO; Davis NL; Falck AJ; Bearer CF; Mooney SM
    J Perinatol; 2018 Feb; 38(2):169-174. PubMed ID: 29095430
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety of "inert" additives or excipients in paediatric medicines.
    Nahata MC
    Arch Dis Child Fetal Neonatal Ed; 2009 Nov; 94(6):F392-3. PubMed ID: 19846397
    [No Abstract]   [Full Text] [Related]  

  • 60. Excipients and additives: hidden hazards in drug products and in product substitution.
    Napke E; Stevens DG
    Can Med Assoc J; 1984 Dec; 131(12):1449-52. PubMed ID: 6498699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.